Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,911,159
+$5,492,666 QoQ
Shares Held
146,832
+22.9% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 213 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ANAB ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,911,159 | 146,832 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,418,493 | 79,670 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,395,149 | 70,032 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,304,517 | 75,262 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,249,477 | 1,272,499 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,114,149 | 490,273 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $484,664 | 36,606 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,227,369 | 36,638 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $866,525 | 34,578 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,445,014 | 64,166 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $401,452 | 18,742 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $315,842 | 17,586 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $715,906 | 35,197 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $76,246 | 3,504 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,605,002 | 51,791 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $272,803 | 10,694 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $449,136 | 22,125 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,186,056 | 47,941 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $923,168 | 26,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $758,301 | 27,961 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $125,734 | 4,849 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $904,886 | 41,990 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $35,474 | 1,650 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,167 | 486 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,772 | 706 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $12,066 | 854 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||